A Case of Neuroparacoccidioidomycosis in Houston, Texas

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2022 Feb 15

PMID 35165582

Authors

Maitreyi Narayan

Swetha Jayavelu

Harsh Goel

Joshua R Rosenthal

Gabriel M Aisenberg

Affiliations

Soon will be listed here.

Abstract

Paracoccidioidomycosis is a systemic fungal disease caused by the dimorphic species endemic to South America. Infection classically presents with pulmonary, mucosal, or reticuloendothelial involvement, though other organs can be involved. Central nervous system involvement is rare, and almost universally reported within the endemic area for the fungus. We present a 60-year-old Brazilian male who complained of occipital headache, ataxia, dysmetria, and dysarthria for two months, diagnosed with neuroparacoccidioidomycosis in Houston, Texas. The patient had a cerebellar mass and a left pulmonary spiculated apical mass suspicious for a lung metastatic malignancy and a preliminary histological report consistent with invasive cryptococcosis. The patient's work and travel history were paramount in achieving the final diagnosis.

References

Da Silva C, Cordeiro A, Gollner A, Cupolilo S, Curzio M . [Paracoccidioidomycosis of the central nervous system: case report]. Arq Neuropsiquiatr. 2000; 58(3A):741-7. DOI: 10.1590/s0004-282x2000000400024. View

Shikanai-Yasuda M, Mendes R, Colombo A, de Queiroz-Telles F, Kono A, Paniago A . Brazilian guidelines for the clinical management of paracoccidioidomycosis. Rev Soc Bras Med Trop. 2017; 50(5):715-740. DOI: 10.1590/0037-8682-0230-2017. View

Martinez R . EPIDEMIOLOGY OF PARACOCCIDIOIDOMYCOSIS. Rev Inst Med Trop Sao Paulo. 2015; 57 Suppl 19:11-20. PMC: 4711199. DOI: 10.1590/S0036-46652015000700004. View

Paniago A, Aguiar J, Aguiar E, da Cunha R, Pereira G, Londero A . [Paracoccidioidomycosis: a clinical and epidemiological study of 422 cases observed in Mato Grosso do Sul]. Rev Soc Bras Med Trop. 2003; 36(4):455-9. DOI: 10.1590/s0037-86822003000400004. View

Casadevall A, Coelho C, Cordero R, Dragotakes Q, Jung E, Vij R . The capsule of . Virulence. 2018; 10(1):822-831. PMC: 6779390. DOI: 10.1080/21505594.2018.1431087. View

Siegel R, Miller K, Fuchs H, Jemal A . Cancer Statistics, 2021. CA Cancer J Clin. 2021; 71(1):7-33. DOI: 10.3322/caac.21654. View

Silletti R, Glezerov V, Schwartz I . Pulmonary paracoccidioidomycosis misdiagnosed as Pneumocystis pneumonia in an immunocompromised host. J Clin Microbiol. 1996; 34(9):2328-30. PMC: 229247. DOI: 10.1128/jcm.34.9.2328-2330.1996. View

Isolan G, Vieira D, Hehn F, Antunes A . Paracoccidioidomycosis simulating brain tumor. Surg Neurol Int. 2014; 5:134. PMC: 4174673. DOI: 10.4103/2152-7806.140656. View

Riechelmann R, Rodrigues L, Avelar T, Xander P, da Costa G, Cannoni L . Isolated neuroparacoccidioidomycosis as a pseudotumoral lesion in the absence of systemic disease. Surg Neurol Int. 2020; 11:151. PMC: 7332495. DOI: 10.25259/SNI_224_2020. View

10.

Martinez R . New Trends in Paracoccidioidomycosis Epidemiology. J Fungi (Basel). 2018; 3(1). PMC: 5715958. DOI: 10.3390/jof3010001. View

11.

Francesconi F, Silva M, Costa R, Francesconi V, Carregal E, Talhari S . Long-term outcome of neuroparacoccidioidomycosis treatment. Rev Soc Bras Med Trop. 2011; 44(1):22-5. DOI: 10.1590/s0037-86822011000100006. View

12.

Rosa Junior M, Amorim A, Baldon I, Martins L, Pereira R, Campos R . Paracoccidioidomycosis of the Central Nervous System: CT and MR Imaging Findings. AJNR Am J Neuroradiol. 2019; 40(10):1681-1688. PMC: 7028579. DOI: 10.3174/ajnr.A6203. View

13.

Santos W, da Silva B, Passos E, Zandonade E, Falqueto A . [Association between smoking and paracoccidioidomycosis: a case-control study in the State of Espírito Santo, Brazil]. Cad Saude Publica. 2003; 19(1):245-53. DOI: 10.1590/s0102-311x2003000100027. View

14.

Bellissimo-Rodrigues F, Bollela V, da Fonseca B, Martinez R . Endemic paracoccidioidomycosis: relationship between clinical presentation and patients' demographic features. Med Mycol. 2012; 51(3):313-8. DOI: 10.3109/13693786.2012.714529. View

15.

Mendes R, Cavalcante R, Marques S, Marques M, Venturini J, Sylvestre T . Paracoccidioidomycosis: Current Perspectives from Brazil. Open Microbiol J. 2017; 11:224-282. PMC: 5695158. DOI: 10.2174/1874285801711010224. View

16.

Queiroz-Telles F, Goldani L, Schlamm H, Goodrich J, Espinel-Ingroff A, Shikanai-Yasuda M . An open-label comparative pilot study of oral voriconazole and itraconazole for long-term treatment of paracoccidioidomycosis. Clin Infect Dis. 2007; 45(11):1462-9. DOI: 10.1086/522973. View

17.

Kayser M, Rickerts V, Drick N, Gerkrath J, Kreipe H, Soudah B . Chronic progressive pulmonary paracoccidioidomycosis in a female immigrant from Venezuela. Ther Adv Respir Dis. 2019; 13:1753466619894913. PMC: 6918496. DOI: 10.1177/1753466619894913. View

18.

Jorge Jr L, Yamashita S, Trindade A, Resende L, Zanini M, Xavier Jr J . Pseudotumoral neuroparacoccidioidomycosis of the posterior fossa: A case report and review of the literature. Surg Neurol Int. 2017; 8:76. PMC: 5445650. DOI: 10.4103/2152-7806.206006. View

19.

Rahman R, Davies L, Mohareb A, Pecanha-Pietrobom P, Patel N, Solomon I . Delayed Relapse of Paracoccidioidomycosis in the Central Nervous System: A Case Report. Open Forum Infect Dis. 2020; 7(4):ofaa077. PMC: 7112725. DOI: 10.1093/ofid/ofaa077. View